Agricultural Biotechnology Market Size, Share and Growth Outlook, 2026

Agricultural Biotechnology Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Agricultural Biotechnology Market size is forecast to increase from $138.05 Billion in 2026 to $277.1 Billion in 2034 at a CAGR of 9.1% between 2026 and 2034.

The Agricultural Biotechnology market report provides detailed analysis and outlook of Agricultural Biotechnology segments including By Technology (Genetic Engineering, Genome Editing, Tissue Culture & Micropropagation, Marker-Assisted Selection, Molecular Diagnostics, Vaccines & Biochips), By Application (Crop Production & Transgenic Crops, Animal Biotechnology & Transgenic Animals, Vaccine & Antibiotic Development, Nutritional Supplements / Biofortification, Biofuels & Biological Products, Aquaculture & Forestry), By Organism Type (Plants, Animals, Microbes), By Crop Type (Corn, Soybean, Cotton, Canola, Rice & Wheat, Fruits & Vegetables), By Product/Type (Hybrid Seeds, Transgenic Seeds, Bio-pesticides, Bio-fertilizers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Agricultural Biotechnology Industry Overview

Seed Genetics, Gene Editing, and Biological Innovation Are Reshaping Agricultural Biotechnology

The agricultural biotechnology industry is undergoing significant transformation as leading agribusiness companies expand investments in advanced genetics, gene-editing technologies, biological crop solutions, and sustainable agricultural systems. Industry participants are increasingly focusing on improving crop resilience, disease resistance, productivity, and environmental sustainability through biotechnology-driven innovation. Growing demand for climate-resilient crops, renewable feedstocks, and precision agriculture solutions is accelerating research and commercialization efforts across seed genetics, crop protection, biologicals, and biofuel applications. Strategic restructuring, manufacturing expansion, and regulatory developments are further shaping the competitive landscape as companies strengthen their biotechnology portfolios and global operational capabilities.

Seed and Genetics Businesses Drive Next-Generation Crop Development

A major industry development is Corteva’s planned seed and genetics spin-off, which will operate under the name Vylor, Inc. The new entity will enter the market with a substantial intellectual property portfolio comprising more than 4,000 germplasm patents and over 2,000 biotechnology patents. Vylor will assume responsibility for the Pioneer, Brevant, and Hoegemeyer seed brands while advancing a development pipeline focused on multi-disease-resistant corn varieties, hybrid wheat programs, proprietary gene-editing technologies, and advanced biofuel traits. This strategic separation highlights the growing importance of specialized genetics businesses within the agricultural biotechnology sector. Following completion of the transaction, Corteva will retain its crop protection and digital agriculture operations, reflecting the industry's increasing segmentation between seed innovation and agricultural input businesses.

Regulatory Support, Biofuels, and Manufacturing Expansion Strengthen Market Growth

The industry is also benefiting from important regulatory and infrastructure developments. Bayer Crop Science reported the reinstatement of low-volatility dicamba herbicide registrations across multiple U.S. states, enabling renewed commercialization of dicamba-based biotechnology solutions supporting soybean and cotton production systems. Beyond crop protection, Bayer has expanded its renewable agriculture initiatives through a strategic alliance with bp focused on scaling camelina production for biofuel applications. The company further strengthened its position through the acquisition of camelina-related assets and the establishment of the Khon Kaen Vegetable Seeds Production Center as an international seed production hub. Syngenta Group continues to expand its biotechnology footprint through the inauguration of a new crop protection formulation facility in Nantong, preparations for large-scale commercialization of hybrid wheat products, expansion of biological manufacturing operations in Orangeburg, South Carolina, and EPA registration of PLINAZOLIN® technology across multiple insecticide product lines. These developments demonstrate the industry's increasing emphasis on advanced genetics, sustainable crop protection technologies, biological inputs, and renewable agricultural feedstocks as key pillars of future agricultural innovation.

Agricultural Biotechnology Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Agricultural Biotechnology market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Bayer AG, Corteva, Inc., Syngenta Group (Sinochem), BASF SE, KWS SAAT SE & Co. KGaA, ChemChina (Adama Agricultural Solutions), FMC Corporation, Evogene Ltd., Yield10 Bioscience, Inc., Benson Hill, Inc.. The Agricultural Biotechnology market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Agricultural Biotechnology industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Agricultural Biotechnology Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Agricultural Biotechnology companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Agricultural Biotechnology markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Agricultural Biotechnology Market Competitive Benchmarking and Company Analysis

Leading companies in Agricultural Biotechnology industry include- Bayer AG, Corteva, Inc., Syngenta Group (Sinochem), BASF SE, KWS SAAT SE & Co. KGaA, ChemChina (Adama Agricultural Solutions), FMC Corporation, Evogene Ltd., Yield10 Bioscience, Inc., Benson Hill, Inc.. The Agricultural Biotechnology market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Agricultural Biotechnology Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Agricultural Biotechnology market remains one of the strongest-performing segments in the country.
The US Agricultural Biotechnology Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Agricultural Biotechnology market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Agricultural Biotechnology industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Agricultural Biotechnology markets

Canada's strong Agricultural Biotechnology sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Agricultural Biotechnology market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Agricultural Biotechnology Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Agricultural Biotechnology market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Agricultural Biotechnology population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Agricultural Biotechnology industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Agricultural Biotechnology market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Agricultural Biotechnology sales through 2034

France Agricultural Biotechnology companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Agricultural Biotechnology Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Agricultural Biotechnology distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Agricultural Biotechnology Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Agricultural Biotechnology market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Agricultural Biotechnology industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Agricultural Biotechnology industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Agricultural Biotechnology Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Agricultural Biotechnology market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Agricultural Biotechnology market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Agricultural Biotechnology Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Agricultural Biotechnology Market Segmentation

By Technology
Genetic Engineering
Genome Editing
Tissue Culture & Micropropagation
Marker-Assisted Selection
Molecular Diagnostics
Vaccines & Biochips
By Application
Crop Production & Transgenic Crops
Animal Biotechnology & Transgenic Animals
Vaccine & Antibiotic Development
Nutritional Supplements / Biofortification
Biofuels & Biological Products
Aquaculture & Forestry
By Organism Type
Plants
Animals
Microbes
By Crop Type
Corn
Soybean
Cotton
Canola
Rice & Wheat
Fruits & Vegetables
By Product/Type
Hybrid Seeds
Transgenic Seeds
Bio-pesticides
Bio-fertilizers

Top Companies in Agricultural Biotechnology Industry

Bayer AG
Corteva, Inc.
Syngenta Group (Sinochem)
BASF SE
KWS SAAT SE & Co. KGaA
ChemChina (Adama Agricultural Solutions)
FMC Corporation
Evogene Ltd.
Yield10 Bioscience, Inc.
Benson Hill, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025